The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Celiac Disease
1.2.3 Parkinson Disease
1.2.4 Alzheimer Disease
1.2.5 Other
1.3 Market by Application
1.3.1 Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Direct-to-consumer Disease Risk and Health Test Market Perspective (2017-2028)
2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Region
2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Direct-to-consumer Disease Risk and Health Test Historic Market Size by Region (2017-2022)
2.2.3 Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Region (2023-2028)
2.3 Direct-to-consumer Disease Risk and Health Test Market Dynamics
2.3.1 Direct-to-consumer Disease Risk and Health Test Industry Trends
2.3.2 Direct-to-consumer Disease Risk and Health Test Market Drivers
2.3.3 Direct-to-consumer Disease Risk and Health Test Market Challenges
2.3.4 Direct-to-consumer Disease Risk and Health Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue
3.1.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue (2017-2022)
3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2017-2022)
3.2 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
3.4 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio
3.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
3.5 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
3.6 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
3.7 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Type
4.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2017-2022)
4.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2023-2028)
5 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Application
5.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Application (2017-2022)
5.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
6.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
6.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
7.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
7.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
8.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
8.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
9.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
9.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
10.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
10.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction
11.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.1.5 23andMe Recent Development
11.2 MyHeritage
11.2.1 MyHeritage Company Detail
11.2.2 MyHeritage Business Overview
11.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction
11.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.2.5 MyHeritage Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Detail
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction
11.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.3.5 LabCorp Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Detail
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction
11.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.4.5 Myriad Genetics Recent Development
11.5 Ancestry.com
11.5.1 Ancestry.com Company Detail
11.5.2 Ancestry.com Business Overview
11.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction
11.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.5.5 Ancestry.com Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction
11.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.6.5 Quest Diagnostics Recent Development
11.7 Gene By Gene
11.7.1 Gene By Gene Company Detail
11.7.2 Gene By Gene Business Overview
11.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction
11.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.7.5 Gene By Gene Recent Development
11.8 DNA Diagnostics Center
11.8.1 DNA Diagnostics Center Company Detail
11.8.2 DNA Diagnostics Center Business Overview
11.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction
11.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.8.5 DNA Diagnostics Center Recent Development
11.9 Invitae
11.9.1 Invitae Company Detail
11.9.2 Invitae Business Overview
11.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction
11.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.9.5 Invitae Recent Development
11.10 IntelliGenetics
11.10.1 IntelliGenetics Company Detail
11.10.2 IntelliGenetics Business Overview
11.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction
11.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.10.5 IntelliGenetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction
11.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.11.5 Ambry Genetics Recent Development
11.12 Living DNA
11.12.1 Living DNA Company Detail
11.12.2 Living DNA Business Overview
11.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction
11.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.12.5 Living DNA Recent Development
11.13 EasyDNA
11.13.1 EasyDNA Company Detail
11.13.2 EasyDNA Business Overview
11.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction
11.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.13.5 EasyDNA Recent Development
11.14 Pathway Genomics
11.14.1 Pathway Genomics Company Detail
11.14.2 Pathway Genomics Business Overview
11.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction
11.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.14.5 Pathway Genomics Recent Development
11.15 Centrillion Technology
11.15.1 Centrillion Technology Company Detail
11.15.2 Centrillion Technology Business Overview
11.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction
11.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.15.5 Centrillion Technology Recent Development
11.16 Xcode
11.16.1 Xcode Company Detail
11.16.2 Xcode Business Overview
11.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction
11.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.16.5 Xcode Recent Development
11.17 Color Genomics
11.17.1 Color Genomics Company Detail
11.17.2 Color Genomics Business Overview
11.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction
11.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.17.5 Color Genomics Recent Development
11.18 Anglia DNA Services
11.18.1 Anglia DNA Services Company Detail
11.18.2 Anglia DNA Services Business Overview
11.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
11.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.18.5 Anglia DNA Services Recent Development
11.19 African Ancestry
11.19.1 African Ancestry Company Detail
11.19.2 African Ancestry Business Overview
11.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction
11.19.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.19.5 African Ancestry Recent Development
11.20 Canadian DNA Services
11.20.1 Canadian DNA Services Company Detail
11.20.2 Canadian DNA Services Business Overview
11.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
11.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.20.5 Canadian DNA Services Recent Development
11.21 DNA Family Check
11.21.1 DNA Family Check Company Detail
11.21.2 DNA Family Check Business Overview
11.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction
11.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.21.5 DNA Family Check Recent Development
11.22 Alpha Biolaboratories
11.22.1 Alpha Biolaboratories Company Detail
11.22.2 Alpha Biolaboratories Business Overview
11.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction
11.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.22.5 Alpha Biolaboratories Recent Development
11.23 Test Me DNA
11.23.1 Test Me DNA Company Detail
11.23.2 Test Me DNA Business Overview
11.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction
11.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.23.5 Test Me DNA Recent Development
11.24 23 Mofang
11.24.1 23 Mofang Company Detail
11.24.2 23 Mofang Business Overview
11.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction
11.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.24.5 23 Mofang Recent Development
11.25 Genetic Health
11.25.1 Genetic Health Company Detail
11.25.2 Genetic Health Business Overview
11.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction
11.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.25.5 Genetic Health Recent Development
11.26 DNA Services of America
11.26.1 DNA Services of America Company Detail
11.26.2 DNA Services of America Business Overview
11.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction
11.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.26.5 DNA Services of America Recent Development
11.27 Shuwen Health Sciences
11.27.1 Shuwen Health Sciences Company Detail
11.27.2 Shuwen Health Sciences Business Overview
11.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction
11.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.27.5 Shuwen Health Sciences Recent Development
11.28 Mapmygenome
11.28.1 Mapmygenome Company Detail
11.28.2 Mapmygenome Business Overview
11.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction
11.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.28.5 Mapmygenome Recent Development
11.29 Full Genomes
11.29.1 Full Genomes Company Detail
11.29.2 Full Genomes Business Overview
11.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction
11.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
11.29.5 Full Genomes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Celiac Disease
Table 3. Key Players of Parkinson Disease
Table 4. Key Players of Alzheimer Disease
Table 5. Key Players of Other
Table 6. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region (2017-2022)
Table 10. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region (2023-2028)
Table 12. Direct-to-consumer Disease Risk and Health Test Market Trends
Table 13. Direct-to-consumer Disease Risk and Health Test Market Drivers
Table 14. Direct-to-consumer Disease Risk and Health Test Market Challenges
Table 15. Direct-to-consumer Disease Risk and Health Test Market Restraints
Table 16. Global Direct-to-consumer Disease Risk and Health Test Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players (2017-2022)
Table 18. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2021)
Table 19. Ranking of Global Top Direct-to-consumer Disease Risk and Health Test Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
Table 23. Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2017-2022)
Table 27. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2023-2028)
Table 29. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2017-2022)
Table 31. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2023-2028)
Table 33. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
Table 43. 23andMe Company Detail
Table 44. 23andMe Business Overview
Table 45. 23andMe Direct-to-consumer Disease Risk and Health Test Product
Table 46. 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 47. 23andMe Recent Development
Table 48. MyHeritage Company Detail
Table 49. MyHeritage Business Overview
Table 50. MyHeritage Direct-to-consumer Disease Risk and Health Test Product
Table 51. MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 52. MyHeritage Recent Development
Table 53. LabCorp Company Detail
Table 54. LabCorp Business Overview
Table 55. LabCorp Direct-to-consumer Disease Risk and Health Test Product
Table 56. LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 57. LabCorp Recent Development
Table 58. Myriad Genetics Company Detail
Table 59. Myriad Genetics Business Overview
Table 60. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product
Table 61. Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 62. Myriad Genetics Recent Development
Table 63. Ancestry.com Company Detail
Table 64. Ancestry.com Business Overview
Table 65. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product
Table 66. Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 67. Ancestry.com Recent Development
Table 68. Quest Diagnostics Company Detail
Table 69. Quest Diagnostics Business Overview
Table 70. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product
Table 71. Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 72. Quest Diagnostics Recent Development
Table 73. Gene By Gene Company Detail
Table 74. Gene By Gene Business Overview
Table 75. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product
Table 76. Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 77. Gene By Gene Recent Development
Table 78. DNA Diagnostics Center Company Detail
Table 79. DNA Diagnostics Center Business Overview
Table 80. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product
Table 81. DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 82. DNA Diagnostics Center Recent Development
Table 83. Invitae Company Detail
Table 84. Invitae Business Overview
Table 85. Invitae Direct-to-consumer Disease Risk and Health Test Product
Table 86. Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 87. Invitae Recent Development
Table 88. IntelliGenetics Company Detail
Table 89. IntelliGenetics Business Overview
Table 90. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product
Table 91. IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 92. IntelliGenetics Recent Development
Table 93. Ambry Genetics Company Detail
Table 94. Ambry Genetics Business Overview
Table 95. Ambry Genetics Direct-to-consumer Disease Risk and Health TestProduct
Table 96. Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 97. Ambry Genetics Recent Development
Table 98. Living DNA Company Detail
Table 99. Living DNA Business Overview
Table 100. Living DNA Direct-to-consumer Disease Risk and Health TestProduct
Table 101. Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 102. Living DNA Recent Development
Table 103. EasyDNA Company Detail
Table 104. EasyDNA Business Overview
Table 105. EasyDNA Direct-to-consumer Disease Risk and Health TestProduct
Table 106. EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 107. EasyDNA Recent Development
Table 108. Pathway Genomics Company Detail
Table 109. Pathway Genomics Business Overview
Table 110. Pathway Genomics Direct-to-consumer Disease Risk and Health TestProduct
Table 111. Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 112. Pathway Genomics Recent Development
Table 113. Centrillion Technology Company Detail
Table 114. Centrillion Technology Business Overview
Table 115. Centrillion Technology Direct-to-consumer Disease Risk and Health TestProduct
Table 116. Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 117. Centrillion Technology Recent Development
Table 118. Xcode Company Detail
Table 119. Xcode Business Overview
Table 120. Xcode Direct-to-consumer Disease Risk and Health TestProduct
Table 121. Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 122. Xcode Recent Development
Table 123. Color Genomics Company Detail
Table 124. Color Genomics Business Overview
Table 125. Color Genomics Direct-to-consumer Disease Risk and Health TestProduct
Table 126. Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 127. Color Genomics Recent Development
Table 128. Anglia DNA Services Company Detail
Table 129. Anglia DNA Services Business Overview
Table 130. Anglia DNA Services Direct-to-consumer Disease Risk and Health TestProduct
Table 131. Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 132. Anglia DNA Services Recent Development
Table 133. African Ancestry Company Detail
Table 134. African Ancestry Business Overview
Table 135. African Ancestry Direct-to-consumer Disease Risk and Health TestProduct
Table 136. African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 137. African Ancestry Recent Development
Table 138. Canadian DNA Services Company Detail
Table 139. Canadian DNA Services Business Overview
Table 140. Canadian DNA Services Direct-to-consumer Disease Risk and Health TestProduct
Table 141. Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 142. Canadian DNA Services Recent Development
Table 143. DNA Family Check Company Detail
Table 144. DNA Family Check Business Overview
Table 145. DNA Family Check Direct-to-consumer Disease Risk and Health TestProduct
Table 146. DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 147. DNA Family Check Recent Development
Table 148. Alpha Biolaboratories Company Detail
Table 149. Alpha Biolaboratories Business Overview
Table 150. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health TestProduct
Table 151. Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 152. Alpha Biolaboratories Recent Development
Table 153. Test Me DNA Company Detail
Table 154. Test Me DNA Business Overview
Table 155. Test Me DNA Direct-to-consumer Disease Risk and Health TestProduct
Table 156. Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 157. Test Me DNA Recent Development
Table 158. 23 Mofang Company Detail
Table 159. 23 Mofang Business Overview
Table 160. 23 Mofang Direct-to-consumer Disease Risk and Health TestProduct
Table 161. 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 162. 23 Mofang Recent Development
Table 163. Genetic Health Company Detail
Table 164. Genetic Health Business Overview
Table 165. Genetic Health Direct-to-consumer Disease Risk and Health TestProduct
Table 166. Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 167. Genetic Health Recent Development
Table 168. DNA Services of America Company Detail
Table 169. DNA Services of America Business Overview
Table 170. DNA Services of America Direct-to-consumer Disease Risk and Health TestProduct
Table 171. DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 172. DNA Services of America Recent Development
Table 173. Shuwen Health Sciences Company Detail
Table 174. Shuwen Health Sciences Business Overview
Table 175. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health TestProduct
Table 176. Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 177. Shuwen Health Sciences Recent Development
Table 178. Mapmygenome Company Detail
Table 179. Mapmygenome Business Overview
Table 180. Mapmygenome Direct-to-consumer Disease Risk and Health TestProduct
Table 181. Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 182. Mapmygenome Recent Development
Table 183. Full Genomes Company Detail
Table 184. Full Genomes Business Overview
Table 185. Full Genomes Direct-to-consumer Disease Risk and Health TestProduct
Table 186. Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
Table 187. Full Genomes Recent Development
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Direct-to-consumer Disease Risk and Health Test Market Share by Type: 2021 VS 2028
Figure 2. Celiac Disease Features
Figure 3. Parkinson Disease Features
Figure 4. Alzheimer Disease Features
Figure 5. Other Features
Figure 6. Global Direct-to-consumer Disease Risk and Health Test Market Share by Application in 2021 & 2028
Figure 7. Online Case Studies
Figure 8. Offline Case Studies
Figure 9. Direct-to-consumer Disease Risk and Health Test Report Years Considered
Figure 10. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Direct-to-consumer Disease Risk and Health Test Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region: 2021 VS 2028
Figure 13. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players in 2021
Figure 14. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
Figure 16. North America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2017-2028)
Figure 18. United States Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Country (2017-2028)
Figure 22. Germany Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Region (2017-2028)
Figure 30. China Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2017-2028)
Figure 38. Mexico Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Country (2017-2028)
Figure 42. Turkey Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. 23andMe Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 45. MyHeritage Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 46. LabCorp Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 47. Myriad Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 48. Ancestry.com Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 49. Quest Diagnostics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 50. Gene By Gene Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 51. DNA Diagnostics Center Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 52. Invitae Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 53. IntelliGenetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 54. Ambry Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 55. Living DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 56. EasyDNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 57. Pathway Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 58. Centrillion Technology Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 59. Xcode Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 60. Color Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 61. Anglia DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 62. African Ancestry Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 63. Canadian DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 64. DNA Family Check Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 65. Alpha Biolaboratories Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 66. Test Me DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 67. 23 Mofang Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 68. Genetic Health Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 69. DNA Services of America Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 70. Shuwen Health Sciences Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 71. Mapmygenome Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 72. Full Genomes Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed